share_log

Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity

Cannabis Extraction Company Ayurcann To Merge With Arogo, Resulting In $210M Entity

大麻股提取公司阿尤坎將與Arogo合併,結果將是2.1億美元的實體。
Benzinga ·  06/28 21:57

Canadian cannabis extraction company Ayurcann Holdings Corp. (CSE:AYUR) (OTCQB:AYURF) (FSE: 3ZQ0) and a special purpose acquisition company Arogo Capital Acquisition Corporation (NASDAQ:AOGO) entered into a definitive business combination agreement. The combined company will be worth $210 million.

加拿大大麻提取公司阿育坎控股公司(CSE: AYUR)(場外交易代碼:AYURF)(FSE:3ZQ0)和一家特殊目的收購公司Arogo Capital Acquisital Acquisition Corporation(納斯達克股票代碼:AOGO)簽訂了最終的業務合併協議。合併後的公司將價值2.1億美元。

"Ayurcann is one of the most innovative companies we have encountered, particularly in cannabis extraction and product development," stated Suradech Taweesaengsakulthai, CEO and director of Arogo. "With their impressive achievements and forward-looking plans, this business combination is set to drive the business onto a new growth trajectory, enhancing its capabilities and expanding the market reach in meaningful ways."

Arogo首席執行官兼董事Suradech Taweesaengsakulthai表示:“阿育康是我們遇到的最具創新性的公司之一,特別是在大麻提取和產品開發方面。”“憑藉他們令人印象深刻的成就和前瞻性計劃,這種業務合併將推動業務走上新的增長軌道,增強其能力並以有意義的方式擴大市場範圍。”

Miami, Florida and Toronto, Canada-based cannabis company highlighted 100% year-over-year growth of gross revenue over the last three audited financial reporting years.

總部位於佛羅里達州邁阿密和加拿大多倫多的大麻公司強調,在過去三個經審計的財務報告年度中,總收入同比增長了100%。

Marijuana Extraction Company Ayurcann Reports 127.7% YoY Revenue Growth For The Third Quarter

大麻提取公司Ayurcann報告稱,第三季度收入同比增長127.7%

"We are proud of our team for what we have achieved as a company," Igal Sudman, chief executive officer of Ayurcann stated. "The business combination with Arogo, is our next step in growing the company nationally while allowing us to also look for international opportunities."

阿育肯首席執行官伊加爾·蘇德曼表示:“我們爲我們的團隊作爲一家公司取得的成就感到自豪。”“與Arogo的業務合併是我們在全國範圍內發展公司的下一步,同時也使我們能夠尋找國際機會。”

Merger Highlights

合併亮點

Under the deal, Ayurcann will pay Arogo $19.6 million in cash. At the same time, it is expected that Ayrucann shareholders will benefit from "an implied pro forma enterprise value of approximately $210 million, at a price of $10.00 per share."

根據該協議,阿育肯將向Arogo支付1,960萬美元的現金。同時,預計Ayrucann的股東將受益於 “隱含的預計企業價值約2.1億美元,每股價格爲10.00美元”。

The transaction is expected to close in the second half of 2024, subject to the receipt of all regulators, court, shareholders and other approvals, and the satisfaction or waiver of all customary closing conditions.

該交易預計將於2024年下半年完成,但須獲得所有監管機構、法院、股東和其他方面的批准,並滿足或放棄所有慣例成交條件。

Under the transaction, ARC Group Limited will receive finder's fees in the amount of 799,731 common shares of the company.

根據該交易,ARC集團有限公司將獲得該公司799,731股普通股的發現費。

Currently there are 194.7 million Ayurcann shares. Upon the transaction, the company projects that 260 million shares will be issued and outstanding, which will be consolidated on a 10:1 ratio, resulting in around 26 million shares.

阿育肯目前有1.947億股股票。交易後,該公司預計將發行和流通2.6億股股票,這些股票將按10:1的比例進行合併,形成約2600萬股。

Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows

新報告顯示,通過稅收改革,加拿大大麻公司的估值可能會飆升多達300%

Photo: Courtesy of Pasuwan via Shutterstock

照片:由 Pasuwan 通過 Shutterstock 提供

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論